Cargando…

The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis

Few prospective studies have reported the cumulative incidence of venous thromboembolism (VTE) in the intensive care unit (ICU), especially for patients receiving guideline-recommended VTE prophylaxis. We aimed to design a prospective observational study to investigate the cumulative incidence and r...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chuanlin, Zhang, Zeju, Mi, Jie, Wang, Xueqin, Zou, Yujun, Chen, Xiaoya, Nie, Zhi, Luo, Xinyi, Gan, Ruiying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571428/
https://www.ncbi.nlm.nih.gov/pubmed/31169685
http://dx.doi.org/10.1097/MD.0000000000015833
_version_ 1783427414054928384
author Zhang, Chuanlin
Zhang, Zeju
Mi, Jie
Wang, Xueqin
Zou, Yujun
Chen, Xiaoya
Nie, Zhi
Luo, Xinyi
Gan, Ruiying
author_facet Zhang, Chuanlin
Zhang, Zeju
Mi, Jie
Wang, Xueqin
Zou, Yujun
Chen, Xiaoya
Nie, Zhi
Luo, Xinyi
Gan, Ruiying
author_sort Zhang, Chuanlin
collection PubMed
description Few prospective studies have reported the cumulative incidence of venous thromboembolism (VTE) in the intensive care unit (ICU), especially for patients receiving guideline-recommended VTE prophylaxis. We aimed to design a prospective observational study to investigate the cumulative incidence and risk factors of ICU-acquired VTE for those populations. We prospectively studied 281 consecutively included patients in the ICU at a single center. All patients provided informed consent. Patients received ultrasound evaluation and were followed for VTE before ICU discharge or within 28 days of ICU stay. The type of VTE thromboprophylaxis was also recorded for all patients. Variables from univariate analyses that were associated with VTE were included in the binary logistic regression analysis to determine VTE predictors. The cumulative VTE incidence with 95% confidence interval (CI) was estimated using Kaplan–Meier methods. Patients had a median age of 60 years (range, 18–89) and an acute physiology and chronic health evaluation II score of 17 (range, 4–36). Despite all patients receiving guideline-recommended thromboprophylaxis, the cumulative incidence of VTE at 7, 14, 21, and 28 days was 4.45% (95% CI 2.55–7.71), 7.14% (95% CI 4.61–10.97), 7.53% (95% CI 4.92–11.43), and 9.55% (95% CI 6.55–13.81), respectively. Central venous catheter use (P = .002, odds ratio [OR] = 4.50), Caprini score (P = .012, OR = 1.20), and ICU length of stay (P = .006, OR = 1.08) were independent risk factors related to the incidence of VTE for patients admitted to the ICU. Our prospective observational study found that the 28-day cumulative incidence of VTE was relatively high for patients admitted to the ICU, despite the use of guideline-recommended thromboprophylaxis. Patients with femoral central venous catheter, prolonged ICU length of stay, or a high Caprini score may have an increased risk of developing VTE.
format Online
Article
Text
id pubmed-6571428
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-65714282019-07-22 The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis Zhang, Chuanlin Zhang, Zeju Mi, Jie Wang, Xueqin Zou, Yujun Chen, Xiaoya Nie, Zhi Luo, Xinyi Gan, Ruiying Medicine (Baltimore) Research Article Few prospective studies have reported the cumulative incidence of venous thromboembolism (VTE) in the intensive care unit (ICU), especially for patients receiving guideline-recommended VTE prophylaxis. We aimed to design a prospective observational study to investigate the cumulative incidence and risk factors of ICU-acquired VTE for those populations. We prospectively studied 281 consecutively included patients in the ICU at a single center. All patients provided informed consent. Patients received ultrasound evaluation and were followed for VTE before ICU discharge or within 28 days of ICU stay. The type of VTE thromboprophylaxis was also recorded for all patients. Variables from univariate analyses that were associated with VTE were included in the binary logistic regression analysis to determine VTE predictors. The cumulative VTE incidence with 95% confidence interval (CI) was estimated using Kaplan–Meier methods. Patients had a median age of 60 years (range, 18–89) and an acute physiology and chronic health evaluation II score of 17 (range, 4–36). Despite all patients receiving guideline-recommended thromboprophylaxis, the cumulative incidence of VTE at 7, 14, 21, and 28 days was 4.45% (95% CI 2.55–7.71), 7.14% (95% CI 4.61–10.97), 7.53% (95% CI 4.92–11.43), and 9.55% (95% CI 6.55–13.81), respectively. Central venous catheter use (P = .002, odds ratio [OR] = 4.50), Caprini score (P = .012, OR = 1.20), and ICU length of stay (P = .006, OR = 1.08) were independent risk factors related to the incidence of VTE for patients admitted to the ICU. Our prospective observational study found that the 28-day cumulative incidence of VTE was relatively high for patients admitted to the ICU, despite the use of guideline-recommended thromboprophylaxis. Patients with femoral central venous catheter, prolonged ICU length of stay, or a high Caprini score may have an increased risk of developing VTE. Wolters Kluwer Health 2019-06-07 /pmc/articles/PMC6571428/ /pubmed/31169685 http://dx.doi.org/10.1097/MD.0000000000015833 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Research Article
Zhang, Chuanlin
Zhang, Zeju
Mi, Jie
Wang, Xueqin
Zou, Yujun
Chen, Xiaoya
Nie, Zhi
Luo, Xinyi
Gan, Ruiying
The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis
title The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis
title_full The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis
title_fullStr The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis
title_full_unstemmed The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis
title_short The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis
title_sort cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571428/
https://www.ncbi.nlm.nih.gov/pubmed/31169685
http://dx.doi.org/10.1097/MD.0000000000015833
work_keys_str_mv AT zhangchuanlin thecumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis
AT zhangzeju thecumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis
AT mijie thecumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis
AT wangxueqin thecumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis
AT zouyujun thecumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis
AT chenxiaoya thecumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis
AT niezhi thecumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis
AT luoxinyi thecumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis
AT ganruiying thecumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis
AT zhangchuanlin cumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis
AT zhangzeju cumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis
AT mijie cumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis
AT wangxueqin cumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis
AT zouyujun cumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis
AT chenxiaoya cumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis
AT niezhi cumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis
AT luoxinyi cumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis
AT ganruiying cumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis